Risk groups in patients with bladder cancer treated with radical cystectomy: Statistical and clinical model improving homogeneity

Journal of Urology

Volumn 174, Issue 4 I, 2005, Pages 1226-1230

  Solsona, E ^a,b   Iborra, I ^a   Dumont, R ^a   Rubio, J ^a   Casanova, J L ^a   Almenar, S ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b Department of Urology ^*  (Spain)

Author keywords

Bladder neoplasms; Cystectomy; Data interpretation; Risk assessment; Statistical

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER MORTALITY; CANCER STAGING; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HIGH RISK POPULATION; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL MODEL; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; TUMOR VOLUME; URINARY DIVERSION;

EID: 24944484197     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000173920.31824.2f     Document Type: Article

References (18)

1. Dalbagni, G., Genega, E., Hashibe, M., Zhang, Z.-F., Russo, P., Herr, H. et al: Cystectomy for bladder cancer: a contemporary series. J Urol, 165: 1111, 2001
2. Madersbacher, S., Hochreiter, W., Burkhard, F., Thalmann, G. N., Danuser, H., Markwalder, R. et al: Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol, 21: 690, 2003
3. Stein, J. P., Lieskovsky, G., Cote, R., Groshen, S., Feng, A. C., Boyd, S. et al: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol, 19: 666, 2001
4. Advanced Bladder Cancer Meta-analysis Collaboration: Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet, 361: 1927, 2003
5. Stockle, M., Wellek, S., Meyenburg, W., Voges, G. E., Fischer, U., Gertenbach, U. et al: Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: prognostic impact of lymph node involvement. Urology, 48: 868, 1996
6. Freiha, F., Reese, J. and Torti, F. M.: A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol, 155: 495, 1996
7. Bassi, P., Ferrante, G. D., Piazza, N., Spinadin, R., Carando, R., Pappagallo, G. et al: Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patients cohort. J Urol, 161: 1494, 1999
8. Frazier, H. A., Robertson, J. E., Dodge, R. K. and Paulson, D. F.: The value of pathological factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer, 71: 3993, 1993
9. Sylvester, R. and Sternberg, C.: The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why. Ann Oncol, 11: 851, 2000
10. Mills, R. D., Turner, W. H., Fleischmann, A., Markwalder, R., Thalmann, G. N. and Studer, U. E.: Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol, 166:19, 2002
11. Stein, J. P., Cai, J., Groshen, S. and Skinner, D. G.: Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: the concept of lymph node density. J Urol, 170: 35, 2003
12. Lerner, S. P., Skinner, D. G., Lieskovsky, G., Boyd, S. D., Groshen, S. L., Ziogas, A. et al: The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol, 149: 758, 1993
13. Vieweg, J., Gschwend, J. E., Herr, H. W. and Fair, W. R.: Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol, 161: 449, 1999
14. Esrig, D., Freeman, J. A., Elmajian, A. D., Stein, J. P., Chen, S.-C., Groshen, S. et al: Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol, 156: 1071, 1996
15. Ngninkeu, B. N., Lorge, F., Moulin, P., Jamart, J. and Van Cangh, P. J.: Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J Urol, 169: 149, 2003
16. Pagano, F., Bassi, P., Drago, F. G. L., Piazza, N., Abatangelo, G., Pappagallo, G. L. et al: Is stage pT4a (D1) realiable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrrent bladder cancer? A necessary distinction for contiguous or non contiguous involvement. J Urol, 155: 244, 1996
17. Schellhammer, P. F., Bean, M. A. and Whitmore, W. F., Jr.: Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis. J Urol, 118: 399, 1977
18. Vieweg, J., Gschwend, J. E., Herr, H. W. and Fair, W. R.: The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol, 161: 72, 1999